Buy more and hold!_老虎社区_美港股上老虎

Buy more and hold!

TobyZacharias
2021-12-15

$Galera Therapeutics, Inc.(GRTX)$ Company plans to discuss avasopasem data with the FDA in 2022 together with the randomized Phase 2b trial could suport an NDA submission, ➡️ other upcoming catalyst including initial data from GREO-1 trial (trials in lung and pancreatic cancer) in the first half of 2022, BTIG Upgrades to Buy price target 15

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":607229815,"tweetId":"607229815","gmtCreate":1639549736129,"gmtModify":1639550587773,"author":{"id":9000000000000376,"authorId":9000000000000376,"authorIdStr":"9000000000000376","name":"TobyZacharias","avatar":"https://static.tigerbbs.com/78bec073397d54a68f80879dd87fd45c","vip":8,"userType":8,"introduction":"运营账号","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":18,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"Buy more and hold!","extraTitle":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/GRTX\">$Galera Therapeutics, Inc.(GRTX)$</a> Company plans to discuss avasopasem data with the FDA in 2022 together with the randomized Phase 2b trial could suport an NDA submission, ➡️ other upcoming catalyst including initial data from GREO-1 trial (trials in lung and pancreatic cancer) in the first half of 2022, BTIG Upgrades to Buy price target 15</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/GRTX\">$Galera Therapeutics, Inc.(GRTX)$</a> Company plans to discuss avasopasem data with the FDA in 2022 together with the randomized Phase 2b trial could suport an NDA submission, ➡️ other upcoming catalyst including initial data from GREO-1 trial (trials in lung and pancreatic cancer) in the first half of 2022, BTIG Upgrades to Buy price target 15</p></body></html>","text":"$Galera Therapeutics, Inc.(GRTX)$ Company plans to discuss avasopasem data with the FDA in 2022 together with the randomized Phase 2b trial could suport an NDA submission, ➡️ other upcoming catalyst including initial data from GREO-1 trial (trials in lung and pancreatic cancer) in the first half of 2022, BTIG Upgrades to Buy price target 15","highlighted":1,"essential":1,"paper":2,"likeSize":5,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/607229815","repostId":0,"isVote":1,"tweetType":1,"viewCount":1797,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["GRTX"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":288,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}